X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (52405) 52405
Newsletter (140) 140
Book Chapter (125) 125
Magazine Article (61) 61
Newspaper Article (17) 17
Dissertation (10) 10
Publication (8) 8
Reference (4) 4
Book / eBook (3) 3
Web Resource (2) 2
Book Review (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44944) 44944
female (27688) 27688
male (27685) 27685
middle aged (24627) 24627
aged (21681) 21681
oncology (17432) 17432
adenocarcinoma (17050) 17050
adenocarcinoma - secondary (16891) 16891
cancer (15283) 15283
adult (14344) 14344
adenocarcinoma - pathology (13197) 13197
metastasis (9388) 9388
surgery (9338) 9338
prognosis (8828) 8828
carcinoma (8221) 8221
aged, 80 and over (8120) 8120
adenocarcinoma - surgery (7315) 7315
tumors (7302) 7302
neoplasm staging (6726) 6726
chemotherapy (6520) 6520
adenocarcinoma - drug therapy (6111) 6111
animals (5903) 5903
immunohistochemistry (5686) 5686
pathology (5606) 5606
retrospective studies (5552) 5552
lung neoplasms - pathology (5537) 5537
lymphatic metastasis (5413) 5413
expression (5250) 5250
treatment outcome (5229) 5229
survival (5098) 5098
medicine & public health (4755) 4755
research (4659) 4659
survival rate (4654) 4654
analysis (4628) 4628
adenocarcinoma - metabolism (4589) 4589
care and treatment (4536) 4536
liver neoplasms - secondary (4395) 4395
follow-up studies (4355) 4355
adenocarcinoma - diagnosis (4104) 4104
cell line, tumor (4080) 4080
adenocarcinoma - mortality (4012) 4012
lung cancer (4003) 4003
gastroenterology & hepatology (3989) 3989
mice (3941) 3941
adenocarcinoma - genetics (3925) 3925
pancreatic cancer (3830) 3830
antineoplastic combined chemotherapy protocols - therapeutic use (3816) 3816
stomach neoplasms - pathology (3805) 3805
diagnosis (3608) 3608
apoptosis (3464) 3464
health aspects (3397) 3397
colorectal cancer (3270) 3270
adenocarcinoma - therapy (3172) 3172
diagnosis, differential (3171) 3171
proteins (3169) 3169
pancreatic neoplasms - pathology (3157) 3157
metastases (3091) 3091
gene expression (3062) 3062
lung neoplasms - secondary (3043) 3043
prostatic neoplasms - pathology (3043) 3043
risk factors (3003) 3003
tomography, x-ray computed (2974) 2974
neoplasm invasiveness (2911) 2911
patients (2731) 2731
medical prognosis (2672) 2672
development and progression (2569) 2569
genetic aspects (2563) 2563
cancer therapies (2545) 2545
colorectal neoplasms - pathology (2542) 2542
mutation (2540) 2540
combined modality therapy (2527) 2527
adenocarcinoma - diagnostic imaging (2487) 2487
survival analysis (2450) 2450
disease-free survival (2418) 2418
cell biology (2404) 2404
biopsy (2391) 2391
therapy (2354) 2354
adenocarcinoma - complications (2350) 2350
prostate cancer (2281) 2281
gene expression regulation, neoplastic (2229) 2229
neoplasm metastasis (2212) 2212
radiotherapy (2211) 2211
time factors (2193) 2193
stomach cancer (2154) 2154
bone neoplasms - secondary (2135) 2135
colonic neoplasms - pathology (2119) 2119
lung neoplasms - genetics (2107) 2107
medicine (2090) 2090
cell proliferation (2061) 2061
biomarkers, tumor - metabolism (2044) 2044
research article (2044) 2044
lung neoplasms - drug therapy (2016) 2016
studies (1993) 1993
abridged index medicus (1973) 1973
disease progression (1944) 1944
kinases (1931) 1931
cells (1887) 1887
prospective studies (1871) 1871
gastric cancer (1861) 1861
breast cancer (1846) 1846
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (49220) 49220
Japanese (1628) 1628
French (928) 928
Spanish (653) 653
German (588) 588
Chinese (330) 330
Italian (238) 238
Russian (180) 180
Polish (116) 116
Portuguese (99) 99
Danish (37) 37
Dutch (36) 36
Hungarian (35) 35
Korean (33) 33
Czech (30) 30
Romanian (21) 21
Serbian (18) 18
Bulgarian (16) 16
Croatian (13) 13
Norwegian (11) 11
Turkish (11) 11
Hebrew (9) 9
Slovak (5) 5
Swedish (4) 4
Ukrainian (4) 4
Finnish (3) 3
Icelandic (2) 2
Greek (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 4/2007, Volume 99, Issue 7, pp. 545 - 557
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 878 - 886
Purpose To analyze the long-term survival and tumor control outcomes after stereotactic body radiotherapy (SBRT) for metastases limited in number and extent.... 
Radiology | Hematology, Oncology and Palliative Medicine | Stereotactic body radiotherapy | Breast cancer | Oligometastases | Survival | Metastases | ACR PRACTICE GUIDELINES | PHASE I/II TRIAL | HEPATIC RESECTION | CELL LUNG-CANCER | LIVER METASTASES | ONCOLOGY ASTRO | ONCOLOGY | COLORECTAL-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | AMERICAN SOCIETY | RADIATION-THERAPY SBRT | TUMOR VOLUME | Bone Neoplasms - mortality | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - mortality | Radiosurgery - adverse effects | Brain Neoplasms - surgery | Esophageal Neoplasms - pathology | Brain Neoplasms - secondary | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Radiosurgery - methods | Colorectal Neoplasms - mortality | Neoplasm Metastasis - radiotherapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Bone Neoplasms - surgery | Adenocarcinoma - secondary | Head and Neck Neoplasms - pathology | Breast Neoplasms - pathology | Sarcoma - surgery | Breast Neoplasms - mortality | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Head and Neck Neoplasms - mortality | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Radiotherapy | Nuclear radiation | Analysis | Radiation | MULTIVARIATE ANALYSIS | PATIENTS | MAMMARY GLANDS | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | DEATH | REGRESSION ANALYSIS | RADIOTHERAPY | HAZARDS | SKELETON
Journal Article
European journal of endocrinology, ISSN 0804-4643, 2014, Volume 170, Issue 4, pp. 575 - 582
Journal Article
Annals of surgical oncology, ISSN 1534-4681, 2015, Volume 23, Issue 5, pp. 1660 - 1665
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 76, pp. 110 - 117
.... Secondary end-points were progression-free survival, overall survival and safety. Results Seventy-one patients were enrolled from August 2007 to October 2009, 41 MDTC/4 MATC patients and 26 MMTC patients... 
Hematology, Oncology and Palliative Medicine | Sunitinib | Phase II | Thyroid carcinoma | DIAGNOSIS | ANGIOGENESIS | GUIDELINES | INDICATOR | FOLLOW-UP | CANCER | TUMORS | TRIAL | ONCOLOGY | PAPILLARY | EXPRESSION | Lung Neoplasms - drug therapy | Lymph Nodes - pathology | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Lung Neoplasms - secondary | Adenocarcinoma, Follicular - secondary | Adenocarcinoma, Follicular - drug therapy | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Bone Neoplasms - drug therapy | Neck | Carcinoma - pathology | Liver Neoplasms - secondary | Pyrroles - therapeutic use | Carcinoma - secondary | Carcinoma - drug therapy | Thyroid Carcinoma, Anaplastic - drug therapy | Thyroid Carcinoma, Anaplastic - secondary | Carcinoma, Neuroendocrine - drug therapy | Liver Neoplasms - drug therapy | Treatment Outcome | Carcinoma, Neuroendocrine - secondary | Lymphatic Metastasis | Thyroid Neoplasms - drug therapy | Carcinoma, Neuroendocrine - pathology | Carcinoma, Papillary | Thyroid Carcinoma, Anaplastic - pathology | Thyroid Neoplasms - secondary | Indoles - therapeutic use | Aged | Thyroid Neoplasms - pathology | Antimitotic agents | Medical research | Care and treatment | Thyroid cancer | Endothelial growth factors | Medicine, Experimental | Metastasis | Antineoplastic agents | Endothelium | Index Medicus
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
Abstract Purpose To assess preliminary safety and efficacy results of the anti-programmed cell death ligand-1 (anti-PD-L1) durvalumab in combination with... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis
Journal Article
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 06/2005, Volume 29, Issue 6, pp. 764 - 782
Journal Article
Gastrointestinal endoscopy, ISSN 0016-5107, 07/2018, Volume 88, Issue 1, pp. 197 - 197
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
Journal Article